EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say ↧ ↧ EXCLUSIVE: US weighs allowing most pharma licensing deals with Chin... The US is working on rules for pharmaceutical companies investing in China that would likely preserve their ability to strike most licensing deals for Chinese drugs, according to three people who have been briefed on the process.
published
EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say ↧
Open the original public source →
Latest documented BWB result
$META market result
I sold the $META $655 Puts 9/25 for $7.60
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.